Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments.

Autor: Eva Zhang, Nguyen, Thi H. O., Allen, Lilith F., Kedzierski, Lukasz, Rowntree, Louise C., So Young Chang, Wuji Zhang, Habel, Jennifer R., Foo, Isabelle J., Menon, Tejas, Mitchell, Jeni, Leong, Rupert W., Bond, Katherine, Williamson, Deborah A., Kedzierska, Katherine, Christensen, Britt
Zdroj: Gut; Apr2024, Vol. 73 Issue 4, p712-714, 3p
Databáze: Complementary Index